Only one study quantified urinary TFF3 levels in patients after cisplatin treatment, in which an increase to a twofold increase to baseline was observed in patients not diagnosed with clinical AKI by traditional methods at day 10 (97). This evidence concerns the gene TFF3 and acute kidney injury.